Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CBIO
NVCT
Add up to 3 more stocks
CBIO
Crescent Biopharma, Inc.
-3.37%
$13.47-0.47Delayed quote: Oct 6, 2026, 1:24 PM EDT
Market Cap
$500.33M
52W Range
$8.72 - $27.41
NVCT
Nuvectis Pharma, Inc.
-5.80%
$20.15-1.24Delayed quote: Oct 6, 2026, 1:19 PM EDT
Market Cap
$534.71M
52W Range
$5.55 - $29.28
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.14 | 58.88 |
| P/S Ratio | 42.10 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -1407.5% | 0.0% |
| Net Margin | -1371.5% | 0.0% |
| ROE | -99.8% | -306.6% |
| ROA | -89.2% | -124.5% |
| ROIC | -102.6% | -317.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.66 | 1.68 |
| Quick Ratio | 9.66 | 1.68 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | -69.85 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.